v3.26.1
Summary of Significant Accounting Policies - Additional Information (Details)
 3 Months Ended 12 Months Ended
Jan. 26, 2026
USD ($)
$ / shares
shares
Jul. 31, 2025
USD ($)
$ / shares
shares
Mar. 31, 2026
USD ($)
Customer
$ / shares
shares
Dec. 31, 2025
USD ($)
Customer
$ / shares
shares
Mar. 31, 2025
USD ($)
Customer
Dec. 31, 2025
USD ($)
Customer
$ / shares
shares
Dec. 31, 2024
USD ($)
Customer
$ / shares
shares
Concentration Risk [Line Items]              
Fair value of nonmonetary transactions     $ 1,600,000     $ 1,600,000 $ 1,600,000
Common stock, par value | $ / shares     $ 0.000001 $ 0.000001   $ 0.000001 $ 0.000001
Conversion of redeemable convertible preferred stock to common stock on initial public offering, Shares | shares   12,729,240          
Issued shares of common stock upon exercise of warrants | shares   424,033          
Stock issued in settlement of RSUs | shares   34,254          
Impairment of long lived assets           $ 0 $ 0
Software Implementation Costs       $ 600,000      
Product returns allowance       1,000,000   1,000,000 1,000,000
Research and development costs     $ 12,832,000   $ 8,687,000 38,486,000 37,168,000
Unrecognized tax benefits       0   0 $ 0
Deferred offering costs     $ 1,500,000 $ 10,600,000   $ 10,600,000  
Common stock, shares issued | shares     21,359,204 18,316,928   18,316,928 434,720
Maximum [Member]              
Concentration Risk [Line Items]              
Payments due period (in days)           90 years  
Minimum [Member]              
Concentration Risk [Line Items]              
Payments due period (in days)           60 years  
Initial Public Offering              
Concentration Risk [Line Items]              
Net proceeds from initial public offering   $ 102,700,000          
Number of shares, issued | shares   4,600,000          
Common stock, par value | $ / shares   $ 0.000001          
Underwriting discounts and commissions   $ 7,700,000          
Conversion of redeemable convertible preferred stock to common stock on initial public offering, Shares | shares   12,729,240          
Offering price of stock | $ / shares   $ 24          
Secondary offering | Subsequent Event [Member]              
Concentration Risk [Line Items]              
Deferred offering costs $ 600,000            
Over Allotment Option              
Concentration Risk [Line Items]              
Number of shares, issued | shares   600,000          
Follow On Offering              
Concentration Risk [Line Items]              
Number of shares, issued | shares 2,679,600            
Underwriting discounts and commissions $ 4,900,000            
Offering price of stock | $ / shares $ 31            
Common stock, shares issued | shares 2,636,651            
Shares sold by certain selling stockholders | shares 42,949            
Net proceeds after deducting underwriting discounts and commissions before offering expenses $ 75,300,000            
Offering expenses $ 1,500,000            
Accounts Receivable | Customer Consentration Risk              
Concentration Risk [Line Items]              
Number of customers | Customer     4 5   5 3
Accounts Receivable | Customer One | Customer Consentration Risk              
Concentration Risk [Line Items]              
Customer concentration risk, percent     26.60%     25.60% 48.70%
Accounts Receivable | Customer Two | Customer Consentration Risk              
Concentration Risk [Line Items]              
Customer concentration risk, percent     26.10%     22.70% 19.20%
Accounts Receivable | Customer Three | Customer Consentration Risk              
Concentration Risk [Line Items]              
Customer concentration risk, percent     17.30%     15.10% 13.50%
Accounts Receivable | Customer Four | Customer Consentration Risk              
Concentration Risk [Line Items]              
Customer concentration risk, percent     10.00%     14.90%  
Accounts Receivable | Customer Five | Customer Consentration Risk              
Concentration Risk [Line Items]              
Customer concentration risk, percent           10.70%  
Net Sales | Customer Consentration Risk              
Concentration Risk [Line Items]              
Number of customers | Customer     3 3 3 3 3
Net Sales | Customer One | Customer Consentration Risk              
Concentration Risk [Line Items]              
Customer concentration risk, percent     28.90%   22.90% 35.60% 40.90%
Net Sales | Customer Two | Customer Consentration Risk              
Concentration Risk [Line Items]              
Customer concentration risk, percent     24.30%   38.30% 28.80% 21.40%
Net Sales | Customer Three | Customer Consentration Risk              
Concentration Risk [Line Items]              
Customer concentration risk, percent     18.30%   25.00% 20.20% 14.30%